GlassScriptPhysician profile
J J Norris
NPI 1407386345
$3,367.56
in general payments reported to CMS, 2019-2025
21 companies · $934 in 2025
The $934 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $367 · 2023: $897 · 2024: $904 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,734.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $663.96 | 2021-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $513.48 | 2021-2024 | Xarelto |
| Pfizer INC. | $449.74 | 2022-2025 | |
| Ucb, INC. | $381.30 | 2021-2025 | Briviact |
| Abbvie INC. | $227.84 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.75 | 2021-2024 | Jardiance |
| Xeris Pharmaceuticals, INC. | $161.96 | 2023-2025 | Gvoke Hypopen |
| Genzyme Corporation | $132.04 | 2024-2025 | |
| Akebia Therapeutics INC | $125.00 | 2025 | Vafseo |
| Mallinckrodt Hospital Products INC. | $107.13 | 2024-2025 | Terlivaz |
| Gilead Sciences, INC. | $100.10 | 2023-2024 | Veklury |
| Novo Nordisk INC | $76.04 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $74.23 | 2023-2024 | Dificid, Verquvo, Recarbrio |
| Astrazeneca Pharmaceuticals LP | $56.12 | 2024-2025 | |
| Inari Medical, INC. | $22.97 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $21.00 | 2024 | Crysvita |
| Bioxcel Therapeutics, INC. | $20.49 | 2023 | Igalmi |
| Cvrx, INC. | $19.55 | 2025 | Barostim Neo System |
| Cranial Technologies, INC | $18.68 | 2023 | Doc Band |
| E.R. Squibb & Sons, L.L.C. | $14.35 | 2021 | |
| Cmp Pharma, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J J Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.